5fyy: Difference between revisions
Jump to navigation
Jump to search
m Protected "5fyy" [edit=sysop:move=sysop] |
No edit summary |
||
Line 1: | Line 1: | ||
==Crystal structure of the catalytic domain of human JARID1B in complex with N05798a== | ==Crystal structure of the catalytic domain of human JARID1B in complex with Maybridge fragment 3-pyridin-3-ylaniline (N05798a) (ligand modelled based on PANDDA event map)== | ||
<StructureSection load='5fyy' size='340' side='right' caption='[[5fyy]], [[Resolution|resolution]] 2.18Å' scene=''> | <StructureSection load='5fyy' size='340' side='right' caption='[[5fyy]], [[Resolution|resolution]] 2.18Å' scene=''> | ||
== Structural highlights == | == Structural highlights == |
Revision as of 11:04, 20 June 2016
Crystal structure of the catalytic domain of human JARID1B in complex with Maybridge fragment 3-pyridin-3-ylaniline (N05798a) (ligand modelled based on PANDDA event map)Crystal structure of the catalytic domain of human JARID1B in complex with Maybridge fragment 3-pyridin-3-ylaniline (N05798a) (ligand modelled based on PANDDA event map)
Structural highlights
Function[KDM5B_HUMAN] Histone demethylase that demethylates 'Lys-4' of histone H3, thereby playing a central role in histone code. Does not demethylate histone H3 'Lys-9' or H3 'Lys-27'. Demethylates trimethylated, dimethylated and monomethylated H3 'Lys-4'. Acts as a transcriptional corepressor for FOXG1B and PAX9. Favors the proliferation of breast cancer cells by repressing tumor suppressor genes such as BRCA1 and HOXA5. In contrast, may act as a tumor suppressor for melanoma.[1] [2] [3] [4] References
|
|